The Zacks Analyst Blog Highlights: PayPal, Exxon Mobil, Goldman Sachs, Charter Communications and Biogen

For Immediate Release

Chicago, IL – January 15, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: PayPal Holdings, Inc. PYPL, Exxon Mobil Corporation (NYSE:XOM) XOM, The Goldman Sachs Group (NYSE:GS), Inc. GS, Charter Communications (NASDAQ:CHTR), Inc. CHTR and Biogen Inc (NASDAQ:BIIB). BIIB.

Here are highlights from Thursday’s Analyst Blog:

Top Research Reports for PayPal, Exxon Mobil and Goldman Sachs

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including PayPal, Exxon Mobil and Goldman Sachs. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

PayPal shares have outperformed the Zacks Internet Software industry over the past year (+113.2% vs. +96.6%) on the back of robust growth in total payments volume owing to increasing net new active accounts.

Further, strengthening customer engagement on the company’s platform is a major positive. Furthermore, Venmo’s improving monetization efforts and rising adoption rate across various platforms are aiding the total active accounts. Additionally, growing momentum of core peer to peer and PayPal Checkout experiences is a tailwind.

Also, benefits from Honey buyout are positives. However, increasing credit loss reserves owing to macroeconomic projections on account of coronavirus is a serious matter of concern. Further, intensifying digital payment competition is a risk.

(You can read the full research report on PayPal here >>>)

Shares of Exxon Mobil have gained +8.5% in the last six months against the Zacks Integrated International Oil industry’s gain of +11.5%. The Zacks analyst believes that ExxonMobil can combat the coronavirus pandemic-induced volatile crude pricing environment since it can rely on its balance sheet, which has significantly lower debt exposure.

The company has recently chalked out a new five-year program to lower greenhouse gas emissions. The target for elimination of routine flaring in the next decade is another plan which the firm said will align with the initiative of the World Bank.

ExxonMobil’s bellwether status in the energy space, optimal integrated capital structure that has historically produced industry-leading returns and management’s track record of capex discipline across the commodity price cycle makes it a relatively lower-risk energy sector play.

(You can read the full research report on Exxon Mobil here >>>)

Goldman Sachs shares have gained +45.2% over the past three months against the Zacks Financial - Investment Bank industry’s rise of +44.8%. The Zacks analyst believes that business diversification helps Goldman sustain growth. The company’s cost management efforts continue to support bottom line growth.

Earnings estimate have been revised upward prior to the fourth-quarter earnings release. The company has a decent earnings surprise history, outpacing the Zacks Consensus Estimate in three of the trailing four quarters and missed in one. The company’s cost management efforts continue to support bottom line growth.

Moreover, with strong liquidity, Goldman carries a low credit risk in case of any economic downturn. Though, legal issues, high dependence on overseas revenues and volatile client-activity might impede top-line growth, steady capital deployment activities keep us encouraged.

(You can read the full research report on Goldman Sachs here >>>)

Other noteworthy reports we are featuring today include Charter Communications and Biogen.

Legal Marijuana: An Investor’s Dream

Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.

Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.

Download Marijuana Moneymakers FREE >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.